Biologics Contract Manufacturing

News and Events

 

MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services

Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan has recognized MabPlex International Ltd. (MabPlex) with the 2019 Global Growth Excellence Leadership Award. Download Frost & Sullivan’s 11 page report. Read the press release here.
 

MabPlex Congratulates Encure Biopharma with FDA IND Clearance of YH001 for the Treatment of a Broad Range of Cancers

November 13, 2019
MabPlex International Ltd. confirms securing United States Food and Drug Administration (FDA) Investigational New Drug (IND) clearance for Encure Biopharma...
Read More

MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services

October 10, 2019
Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan has...
Read More

MabPlex International Announces Appointment of Dr. Wei Chen (Ph.D) as Chief Executive Officer

August 11, 2019
MabPlex International Ltd (MabPlex) has appointed Wei Chen Ph.D as the company's new Chief Executive Officer (CEO). Dr. Chen, a...
Read More
December
San Diego | December 9 - December 13
X
INFORMATION